AIM
NKTR icon

Ada Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Ada Investment Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$194K Buy
+769
New +$158K 0.13% 339
2015
Q3 		– Sell
-1,716
Closed -$322K – 484
2015
Q2 		$322K Buy
+1,716
New +$295K 0.4% 106

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ada Investment Management's NKTR Position: Q4 2015 in Review

Ada Investment Management opened a new position in Nektar Therapeutics (NKTR) in Q4 2015: 769 shares worth $194K. The stake represents 0.13% of the portfolio and ranks #339 among its holdings. This is a return to the name: Ada Investment Management previously reported a position in NKTR as recently as Q2 2015.

Ada Investment Management first reported a position in NKTR in Q2 2015 and has held it in 2 quarters since. The position peaked at $322K in Q2 2015. 179 funds tracked by Wall St. Rank hold NKTR as of Q4 2015.

  • Ada Investment Management held 769 shares of Nektar Therapeutics worth $194K as of Q4 2015.
  • Nektar Therapeutics was a new Ada Investment Management position in Q4 2015.
  • Nektar Therapeutics made up 0.13% of Ada Investment Management's portfolio in Q4 2015, its #339 holding.
  • Ada Investment Management first reported a position in Nektar Therapeutics in Q2 2015 and has held it in 2 quarters since.
  • Ada Investment Management's Nektar Therapeutics position peaked at $322K in Q2 2015.
  • 179 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.